Colorado-Oregon Altitude Study
Condition: Acute Mountain Sickness Interventions: Drug: Erythropoietin; Drug: Iron sucrose (Venofer); Drug: Sterile Sodium Chloride Sponsor: University of Oregon Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
Condition: Subcutaneous Fat Interventions: Drug: CBL-514 Injection; Other: 0.9% Sodium Chloride Sponsor: Caliway Biopharmaceuticals Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials
Colorado-Oregon Altitude Study
Condition: Acute Mountain Sickness Interventions: Drug: Erythropoietin; Drug: Iron sucrose (Venofer); Drug: Sterile Sodium Chloride Sponsor: University of Oregon Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
Condition: Subcutaneous Fat Interventions: Drug: CBL-514 Injection; Other: 0.9% Sodium Chloride Sponsor: Caliway Biopharmaceuticals Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials
Colorado-Oregon Altitude Study
Condition: Acute Mountain Sickness Interventions: Drug: Erythropoietin; Drug: Iron sucrose (Venofer); Drug: Sterile Sodium Chloride Sponsor: University of Oregon Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
Condition: Subcutaneous Fat Interventions: Drug: CBL-514 Injection; Other: 0.9% Sodium Chloride Sponsor: Caliway Biopharmaceuticals Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials
Colorado-Oregon Altitude Study
Condition: Acute Mountain Sickness Interventions: Drug: Erythropoietin; Drug: Iron sucrose (Venofer); Drug: Sterile Sodium Chloride Sponsor: University of Oregon Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
Condition: Subcutaneous Fat Interventions: Drug: CBL-514 Injection; Other: 0.9% Sodium Chloride Sponsor: Caliway Biopharmaceuticals Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials
Colorado-Oregon Altitude Study
Condition: Acute Mountain Sickness Interventions: Drug: Erythropoietin; Drug: Iron sucrose (Venofer); Drug: Sterile Sodium Chloride Sponsor: University of Oregon Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
Condition: Subcutaneous Fat Interventions: Drug: CBL-514 Injection; Other: 0.9% Sodium Chloride Sponsor: Caliway Biopharmaceuticals Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2023 Category: Research Source Type: clinical trials
Colorado-Oregon Altitude Study
Condition: Acute Mountain Sickness Interventions: Drug: Erythropoietin; Drug: Iron sucrose (Venofer); Drug: Sterile Sodium Chloride Sponsor: University of Oregon Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
Condition: Subcutaneous Fat Interventions: Drug: CBL-514 Injection; Other: 0.9% Sodium Chloride Sponsor: Caliway Biopharmaceuticals Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2023 Category: Research Source Type: clinical trials
A Randomized Controlled Trial of Intranasal Dexmedetomidine
Conditions: Cataract; Preoperative Sedation Intervention: Drug: Dextrometropine and 0.9% sodium chloride solution Sponsor: Guangzhou First People's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2023 Category: Research Source Type: clinical trials
